Succinylation of CTBP1 Mediated by SIRT5 Suppresses MAT1A Expression to Promote the Progression of HCC
Cellular Physiology and Biochemistry · 2025
DOI: 10.33594/000000832 ↗At a glance
Journal article in Cellular Physiology and Biochemistry, 2025. Written by Zhengcai Qiu and 4 co-authors. Institution: Department of General Surgery, Shuyang Hospital Affiliated to Nanjing University of Chinese Medicine, Jiangsu, P.R. China. Major MEDLINE topics: Liver Neoplasms, Carcinoma, Hepatocellular, Alcohol Oxidoreductases, Sirtuins.
Abstract (original language)
Background/Aims: Succinylation, a recently characterized post-translational modification (PTM), is a ubiquitously occurring protein modification implicated in diverse biological processes via regulation of protein function and gene expression. CTBP1 encodes C-terminal binding proteins and generates multiple splice variants. However, the functional significance of CTBP1 succinylation in hepatocellular carcinoma (HCC) remains unexplored.
Methods
Protein succinylation levels were quantified using immunoprecipitation coupled with Western blotting and mass spectrometry. Site-directed mutagenesis identified critical lysine residues targeted by succinylation. Functional impacts of CTBP1 succinylation on HCC cell behaviors were evaluated through CCK8-based cell viability, wound healing, transwell migration, and invasion assays. Molecular mechanisms were elucidated via qRT-PCR and Western blot analyses.
Results
Succinylation levels of CTBP1 were significantly elevated in HCC tumor tissues and cell lines relative to non-tumorous controls. Mass spectrometry and mutagenesis pinpointed K46 and K280 as the primary succinylation sites on CTBP1, with SIRT5 identified as the desuccinylase. Functionally, CTBP1 succinylation enhanced HCC cell proliferation, migration, and invasive potential. Mechanistically, this modification promoted tumor progression by suppressing MAT1A expression—a key regulator of hepatic differentiation and tumorigenesis.
Conclusion
Our study reveals that SIRT5-mediated CTBP1 succinylation drives HCC progression through MAT1A suppression, establishing a novel regulatory axis with therapeutic potential for HCC treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of General Surgery, Shuyang Hospital Affiliated to Nanjing University of Chinese Medicine, Jiangsu, P.R. China.
- Department of General Surgery, Liyang People's Hospital, No. 70 West Jianshe Road, Liyang, 213300, Jiangsu, P.R. China.
Cite
APA
Qiu, Z., Wang, Q., Li, S., Lu, G., & Han, J. (2025). Succinylation of CTBP1 Mediated by SIRT5 Suppresses MAT1A Expression to Promote the Progression of HCC. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000832
Vancouver
Qiu Z, Wang Q, Li S, Lu G, Han J. Succinylation of CTBP1 Mediated by SIRT5 Suppresses MAT1A Expression to Promote the Progression of HCC. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000832
BibTeX
@article{Qiu2025,
author = {Qiu, Zhengcai and Wang, Qipeng and Li, Shangshang and Lu, Guang and Han, Jing},
title = {Succinylation of CTBP1 Mediated by SIRT5 Suppresses MAT1A Expression to Promote the Progression of HCC},
journal = {Cellular Physiology and Biochemistry},
year = {2025},
doi = {10.33594/000000832}
}
EUVIMED